INTRAOPERATIVE FLUORESCENCE STAINING OF MALIGNANT BRAIN TUMORS USING 5-AMINOFLUORESCEIN-LABELED ALBUMIN-Reference-Cited by-同舟云学术

INTRAOPERATIVE FLUORESCENCE STAINING OF MALIGNANT BRAIN TUMORS USING 5-AMINOFLUORESCEIN-LABELED ALBUMIN

Published:2009-03 Issue:3 Volume:64 Page:ons53-ons61
ISSN:2332-4252
Container-title:Operative Neurosurgery
language:en
Short-container-title:

Author:

Kremer Paul,Fardanesh Mahmoudreza,Ding Reinhard,Pritsch Maria,Zoubaa Saida,Frei Eva

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

http://academic.oup.com/ons/article-pdf/64/suppl_1/ONS53/30221371/ons-64-suppl_1-ons53.pdf

Reference39 articles.

1. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumour and its influence on regrowth and prognosis.;Albert;Neurosurgery,1994

2. Identification of tissue sites for increased albumin degradation in sarcoma-bearing mice.;Andersson;J Surg Res,1991

3. Distribution pattern of tenascin-C in glioblastoma: Correlation with angiogenesis and tumor cell proliferation.;Behrem;Pathol Oncol Res,2005

4. Phase II study of MTX-HSA in combination with cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma.;Bolling;Invest New Drugs,2006

5. Initial experience with an ultrasound-integrated single-RACK neuronavigation system.;Bonsanto;Acta Neurochir (Wien),2001

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorimetric sensor for copper and lead using silver nanoparticles functionalized with fluoresceinamine isomer I;Journal of Molecular Structure;2024-11

2. Machine learning approaches in non-contact autofluorescence spectrum classification;PLOS Digital Health;2024-10-09

3. Inflammation-Targeted Drug Delivery Strategies via Albumin-Based Systems;ACS Biomaterials Science & Engineering;2024-01-09

4. Fluorescence imaging-guided surgery: current status and future directions;Biomaterials Science;2024

5. Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma;Polymers;2023-10-02